Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes
- 11 August 2025
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , 820-831
Abstract
Context: The metabolic mechanisms underlying insulin resistance are not fully understood. Metabolomic profiling can reveal compartment-specific variations and identify individuals at risk for type 2 diabetes (T2D). Objective: To characterize insulin-induced metabolomic changes during a hyperinsulinemic–euglycemic clamp and evaluate a derived risk score's predictive value for T2D. Design, Setting, and Participants: Clamp studies were conducted in 80 adults (38 with T2D, 42 without) to measure plasma and muscle metabolites in fasting and hyperinsulinemic states. An insulin resistance metabolomic score was developed and tested in a prospective case–control study (367 cases, 910 controls) from the Women's Health Initiative (28.5-year follow-up). Main Outcome Measures: Metabolite changes during hyperinsulinemia and incident T2D. Results: Hyperinsulinemia altered 79.5% of plasma metabolites (notably fatty acids, lactate, and pyruvate) and 15.8% of muscle metabolites (eg, branched-chain and aromatic amino acids). T2D was associated with higher triglycerides and lower tricarboxylic acid intermediates during clamp. Adiposity amplified insulin-induced increases in plasma lipids. The risk score predicted incident T2D (hazard ratio, 1.20 per SD; 95% CI, 1.09-1.32; P = 7.4 × 10−4). Conclusion: Compartment-specific metabolic responses to insulin are shaped by adiposity and predict future T2D risk, supporting use of metabolomic signatures for early identification and prevention.Keywords
Funding Information
- Congressionally Directed Medical Research Programs
- American Diabetes Association (9-22-PDFPM-04)
- American Diabetes Association (NIDDK UM1 DK078616)
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- U.S. Department of Health and Human Services (75N92021D00001)
- U.S. Department of Health and Human Services (75N92021D00002)
- U.S. Department of Health and Human Services (75N92021D00003)
- U.S. Department of Health and Human Services (75N92021D00004)
- U.S. Department of Health and Human Services (75N92021D00005)
This publication has 32 references indexed in Scilit:
- The clinical consequences of heterogeneity within and between different diabetes typesDiabetologia, 2020
- Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivityMetabolomics, 2020
- Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 DiabetesCanadian Journal of Diabetes, 2018
- Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesisNature Chemical Biology, 2015
- Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort studyThe Lancet Diabetes & Endocrinology, 2014
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesNature, 2014
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin ResistanceCell Metabolism, 2008
- Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up studyThe Lancet, 1992
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985